International Stakeholder Community of Pain Experts and Leaders Call for an Urgent Action on Forced Opioid Tapering | Pain Medicine | Oxford Academic – 29 November 2018
We, the undersigned, stand as a unified community of stakeholders and key opinion leaders deeply concerned about forced opioid tapering in patients receiving long-term prescription opioid therapy for chronic pain.
This is a large-scale humanitarian issue.
As happy as I am to see this declaration, even long after the opioid prescribing guidelines were weaponized to force opioid tapers, I’m appalled that it took 2.5 years of entirely foreseeable consequences for all these doctors to finally speak up.
There’s an impressively long list of signatories to this document, including several that have been vocally pushing for the very restrictions they now call a “large-scale humanitarian issue”. I’m stunned at the hypocrisy. Continue reading
Low Risk of Producing an Opioid Use Disorder in Primary Care by Prescribing Opioids to Prescreened Patients with Chronic Noncancer Pain | Pain Medicine | Oxford Academic – March 2017
This study shows what pain patients have been saying all along: prescribing opioids for patients with chronic pain very rarely causes problems of drug abuse.
To examine the risk of developing aberrant behaviors that might lead to a substance use disorder (addiction) when prescribing opioids for the relief of chronic noncancer pain in primary care settings. Continue reading
The ‘Phony War’ Against Opioids: Some Inconvenient Truths | The Crime ReportThe Crime Report
Anyone who watches TV news will know that America has a major public health problem concerning drug addiction and opioid overdose deaths. In this context, we sometimes hear terms like “prescription opioid epidemic” and “over-prescribing” thrown about indiscriminately.
Hidden inside the hype and misinformation are several inconvenient truths. Public policy on the drug crisis cannot be remotely effective until we embrace such truths and act on them. Continue reading
Introduction: Addiction and Brain Reward and Anti-Reward Pathways – free full-text article /PMC4549070/ – Aug 2011
This is a long and detailed article explaining at length how pain and addiction manifest in neurological processes in various areas of the brain.
It also contradicts the belief that opioids cause addiction, which has motivated the anti-opioid crusaders to make life a hell on earth for pain patients. (see Pain Patients Left to Suffer in ‘Hell on Earth)
Can One Induce Addiction
by Long-Term Treatment of Pain with Opiates? Continue reading
#HPM Crash Course in Submitting Comments to CMS | Matthew Cortland on Patreon – Feb 2018 – by Matthew Cortland
Mr. Cortland gives excellent advice for the best way to write your comments on opioid policy. Though his words are aimed at Hospice & Palliative Medicine (HPM) clinicians, I believe many of us chronic pain patients have just as much knowledge and experience with this subject.
CMS has published their proposed changes to Medicare for 2019.
Here are the changes that, in my view, may be the most concerning to Hospice & Palliative Medicine (HPM) clinicians:
- Starting to crack down on opioid ‘potentiator’ drugs – like gabapentin and pregabalin.
- Limiting opioids to 90 MME per day.
- Making it more difficult for patients to fill two or more long-acting opioids. Continue reading
DEA Raids Dr. Forest Tennant’s Pain Clinic — Pain News Network – November 16, 2017 By Pat Anson, Editor
Agents with the Drug Enforcement Administration have raided the offices and home of Dr. Forest Tennant, a prominent California pain physician, confiscating patient records, appointment books and financial documents.
In a lengthy search warrant, the DEA alleges that Tennant prescribed such high doses of opioid pain medication that his patients must be selling them.
So, the DEA got a search warrant based on their assumptions about his patients’ medical needs and their assumptions about what his patients are doing with their medication – no proof, no evidence, just assumptions. Continue reading
Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives. – PubMed – NCBI – August 2017
I found this evidence that opioid dose reductions are failing in their stated purpose of reducing the rate of Opioid Use Disorder (used to be addiction).
No studies have assessed the comparative effectiveness of guideline-recommended interventions to reduce risk of prescription opioid use disorder among chronic opioid therapy (COT) patients.
We compared the prevalence of prescription opioid use disorder among COT patients from intervention clinics that had implemented opioid dose and risk reduction initiatives for more than 4 years relative to control clinics that had not. Continue reading
Chronic Cancer versus Non-Cancer Pain: A Distinction without a Difference? | GeriPal – Geriatrics and Palliative Care Blog – March 2016 – by Eric Widera, MD (@ewidera)
In 1824, Jeremy Bentham published the “Book of Fallacies” in which he criticized fifty arguments used in political debate and explained the sinister interests that led politicians to use them.
One of these fallacies he describes as the “sham distinction”, now known better as a “distinction without a difference“.
This logical fallacy appeals to a distinction between two two things that ultimately cannot be explained or defended in a meaningful way. Continue reading
The Opioid Epidemic in 6 Charts Designed To Deceive You – By Josh Bloom — October 12, 2017
In this article, Josh Bloom eviscerates Kolodny’s arguments showing the unrelenting anti-opioid bias and disregard for opposing evidence.
Dr. Kolodny, a psychiatrist, is the executive director of Physicians for Responsible Opioid Prescribing (PROP)—a group that played a significant role in creating the disastrous CDC Guideline for Prescribing Opioids for Chronic Pain (2016).
The CDC ended up incorporating much of PROP’s recommendations, which were supposedly designed to help the US mitigate the damage done by opioid drugs, despite the fact that the “evidence” contained in the recommendations had been carefully scrutinized and found unsupportable by FDA scientists.
Terminology of chronic pain: the need to “level the playing field” – Free full-text /PMC4734783/ – Jan 2016 – John F Peppin and Michael E Schatman
This article, published in the Journal of Pain Research, makes it clear that there is NO biological/medical/physical difference between “chronic cancer pain” and “chronic noncancer pain”.
Pain medicine as a separate subspecialty is in its infancy, only fairly recently being recognized as such by the American Board of Medical Specialities. As it continues to find its way in the ever-changing world of medicine, terminology becomes an important consideration.
Terms carry tremendous impact: Continue reading